9 episodes

One of the most common complaints we hear from our patients when we first meet them to discuss their cancer diagnosis and treatment plan is that there is a lack of reliable, available information about cancer. Evaluating what is or isn’t a credible source of information on the internet is challenging, even for the most experienced of Googlers. We are seeking to fill that gap by providing the public with understandable, reliable information about cancer.

Join us as we talk to healthcare experts at Ochsner about what you need to know should you or a loved one receive a cancer diagnosis.

All In Against Cancer Ochsner Cancer Institute

    • Health & Fitness
    • 4.9 • 14 Ratings

One of the most common complaints we hear from our patients when we first meet them to discuss their cancer diagnosis and treatment plan is that there is a lack of reliable, available information about cancer. Evaluating what is or isn’t a credible source of information on the internet is challenging, even for the most experienced of Googlers. We are seeking to fill that gap by providing the public with understandable, reliable information about cancer.

Join us as we talk to healthcare experts at Ochsner about what you need to know should you or a loved one receive a cancer diagnosis.

    Episode 9 - Liver Cancer

    Episode 9 - Liver Cancer

    Liver cancer is one of the most common types of cancer worldwide and represents the third most common cause of cancer-related death globally. About 75% of liver cancers arise from the liver cells – and these cancers are called hepatocellular carcinoma, or HCC.  The majority of the remaining liver cancers arise from the bile ducts that traverse the liver- and these cancers are referred to biliary tract cancers, or cholangiocarcinoma.

    In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Lingling Du, and Ochsner interventional radiologist, Dr. Tyler Sandow, about liver cancer.

    Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for liver cancer.

    • 50 min
    Episode 8 - Prostate Cancer

    Episode 8 - Prostate Cancer

    Prostate cancer is the second most common cancer in males in the United States with almost a quarter of a million men diagnosed each year.  Advances in surgical and radiation techniques have improved the treatment landscape for patients with localized disease, and novel therapies have allowed us to make headway in our management of those with advanced prostate cancer. 

    In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Zoe Larned, and Ochsner urologist, Dr. Sean Collins, about prostate cancer.

    Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for prostate cancer.

    • 43 min
    Episode 7 - Leukemia

    Episode 7 - Leukemia

    Leukemia is one of the most common cancers with over 60,000 new patients receiving this diagnosis each year in the United States.  While leukemia refers to a malignancy of white blood cells, it is an umbrella term for a number of subtypes that carry their own prognoses and treatments.

    In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner hematologic oncologists, Dr. Carter Davis and Dr. Laura Finn about leukemia.

    Tune in to hear more about the signs and symptoms and our approach to the diagnosis and  treatment of this cancer.

    • 48 min
    Episode 6 - Cancer Clinical Trials

    Episode 6 - Cancer Clinical Trials

    Clinical trials represent the fundamental agents of progress in cancer care.  They allow us to move the needle in advancing new therapies and evaluating novel treatment approaches for our patients.  Tens of thousands of cancer patients enroll in clinical trials each year across the United States.

    In this special episode of the All In Against Cancer podcast, join host Dr. Jon Mizrahi in a discussion with with Ochsner medical oncologist, Dr. Marc Matrana, and oncology nurse practitioner, Erin Pierce, to learn more about the role and types of clinical trials in oncology and discuss the unique clinical trial opportunities at Ochsner.  We will also clear up some common misconceptions about trials and touch upon what we envision for the future of clinical research.

    • 42 min
    Episode 5 - Breast Cancer

    Episode 5 - Breast Cancer

    Breast cancer is the most common cancer diagnosis in women in the United States and currently accounts for the second most cancer deaths in women behind lung cancer.  Although more than 260,000 diagnoses of breast cancer are made each year in this country, advances in screening and therapies for this disease have led to continued declines in mortality.

    In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Melanie Sheen, and Ochsner breast surgical oncologist, Dr. Amy Rivere, about breast cancer.

    Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for breast cancer.

    • 1 hr 8 min
    Episode 4 - Colorectal Cancer

    Episode 4 - Colorectal Cancer

    In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner radiation oncologist, Dr. Jeff Burkeen, and Ochsner colorectal surgeon, Dr. Forrest Johnston, about colorectal cancer.

    Colorectal cancer is one of the most common cancers in the United States.  While improvements in screening and early detection have been made, this disease still accounts for over 50,000 deaths in this country per year.  Advances in systemic, radiation and surgical therapies have improved outcomes for patients with colorectal cancer, and increasingly, oncologists are able to tailor treatments to target individual tumor vulnerabilities.  

    Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for colorectal cancer.

    • 47 min

Customer Reviews

4.9 out of 5
14 Ratings

14 Ratings

Top Podcasts In Health & Fitness

Scicomm Media
Jay Shetty
Aubrey Gordon & Michael Hobbes
Slumber Studios
Lewis Howes
Peter Attia, MD

You Might Also Like